Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CTI BIOPHARMA CORP (CTI)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 9.6 | | | | | 0.5 | 0.6 | 0.6 |
| Asset turnover | 0.5 | 0.0 | 0.0 | 0.0 | 0.4 | 0.4 | 0.6 | 0.1 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -505.1% | | -927.5% | -199.6% | -136.5% | | | |
| ROIC (including intangibles) | -125.0% | 1058.0% | -655.8% | -1322.9% | -87.1% | -385.4% | 453.1% | 914.6% |
| ROE | 454.0% | -2530.7% | -119.3% | -222.6% | -60.8% | -244.6% | -622.5% | -243.3% |
| ROA | -63.4% | -131.6% | -82.0% | -86.2% | -35.8% | -71.7% | -75.6% | -80.0% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 104.1 | | | 0.0 | 0.0 | 0.0 | 2.4 | 6.4 |
| Days payables outstanding | 208.6 | | | | | 2,595.1 | 1,915.7 | 1,991.3 |
| Days inventory outstanding | 76.1 | | | | | | 404.2 | 535.3 |
| Cash conversion cycle | -28.3 | | | | | -2,595.1 | -1,509.0 | -1,449.7 |
|